Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11918584 Combination therapy including a KRAS

Patent 11918584 was granted and assigned to Amgen on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

James Russell Lipford0

Anne Y. Saiki0

Jude Robert Canon0

Karen Louise Rex0

Date of Patent

March 5, 2024

0

Patent Application Number

178705730

Date Filed

July 21, 2022

0

Patent Citations

US Patent 7700636 Thiadiazole compounds and methods of use

0

US Patent 7025962 Mammalian cell surface antigens; related reagents

0

US Patent 7354944 Thiadiazole compounds and methods of use

0

US Patent 7361760 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases

0

US Patent 7514566 Thiazole compounds and methods of use

0

US Patent 7618632 Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies

0

US Patent 7919504 Thiadiazole modulators of PKB

0

US Patent 7919514 Thiadiazole compounds and methods of use

0

...

Patent Citations Received

US Patent 12083121 Substituted piperazines as KRAS G12C inhibitors

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11918584 Combination therapy including a KRAS

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool